BP

Ben Price

Percheron Therapeutics Limited | Non-Executive Director
Dr Price is an experienced biotech executive and entrepreneur with depth of expertise across clinical asset investment strategy, evaluation, financing and execution. Additional leadership experience includes R&D, Medical, and strategic corporate functions. He is also a member of Governance Committee.

Company and Role

Company
Title
Tenure
Since
PER
Percheron Therapeutics Limited
  • Non-Executive Director
3yrs, 4mthOct 2021

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PER
Percheron Therapeutics Limited
25/11/24999,805N/A4,000,000N/A
26/09/23999,805N/A1,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PER
Percheron Therapeutics Limited
25/11/24
Issued
3,000,000$0.063$189,000Issue of options
26/09/23
Buy
400,000$0.071$28,400On-market trade
PER
Percheron Therapeutics Limited
26/09/23
Buy
400,000$0.071$28,400On-market trade
03/10/22
Buy
701$0.083$58On-market trade.
30/09/22
Buy
105,208$0.086$9,047On-market trade. Average